The ₹500-crore specialty chemicals issue offers exposure to import substitution and export growth, but high valuation, customer concentration and low capacity utilisation have divided analyst opinion
IPO Opens with Mixed Analyst Views
Prasol Chemicals’ initial public offering has opened for subscription in the price band of ₹643–676 per share. The ₹500-crore issue comprises a fresh issue of ₹80 crore and an offer for sale worth ₹420 crore. The IPO will remain open until September 10, while the shares are scheduled to list on the BSE and NSE on September 16.
The lot size is 22 shares, requiring a minimum investment of ₹14,872 at the upper price band. Half of the issue has been reserved for qualified institutional buyers, while retail investors have been allocated 35 per cent and non-institutional investors 15 per cent.
Analysts have taken different views on the offer. Ventura has assigned a ‘Subscribe’ rating, citing the company’s specialised product portfolio, manufacturing capabilities and export opportunities. Swastika has given a ‘Neutral’ rating, pointing to the company’s strong growth but also highlighting the demanding valuation and operational risks.
Specialty Chemicals Portfolio Supports Business
Prasol Chemicals manufactures more than 150 specialty chemical products used in performance chemicals, paints, inks, construction, adhesives, pharmaceuticals, agrochemicals, home care and personal care.
The company is engaged in the production of acetone- and phosphorus-based specialty chemicals, along with customised products involving complex and differentiated chemistries. It is also the largest importer of acetone in India during the period cited by the company and the only domestic manufacturer of isophorone.
Its products are supplied to more than 1,600 customers across 69 countries. The company also operates consignment stock points in Rotterdam and Houston, helping it serve overseas markets and reduce delivery-related limitations.
Prasol’s manufacturing operations are supported by distributed control system automation and a 37-member research and development team. These capabilities could help the company develop customised products, improve process efficiency and increase its share of higher-value chemical applications.
Revenue and Profit Growth Remain Strong
Prasol Chemicals has reported significant improvement in its financial performance over the past three years. Standalone revenue from operations rose to approximately ₹1,232.5 crore in FY26 from ₹1,012.5 crore in FY25 and ₹876.6 crore in FY24.
Standalone profit increased to around ₹83.1 crore in FY26 from ₹43.6 crore in FY25 and ₹18.1 crore in FY24. The improvement reflects higher sales, better operating leverage and stronger profitability across its product portfolio.
The company’s EBITDA margin also improved to approximately 11.7 per cent in FY26. Swastika noted that the company’s return on net worth stood at around 18.5 per cent, which was ahead of several industry peers.
However, investors must assess whether the recent improvement can be sustained. Specialty chemical margins are sensitive to raw-material prices, product mix, demand conditions and the company’s ability to pass higher costs to customers.
Acetone and Phosphorus Products Drive Revenue
Acetone-based specialty chemicals contributed approximately 43 per cent of revenue in FY26, making it the company’s largest business segment. Phosphorus-based specialty chemicals accounted for around 38 per cent, while other specialty chemicals contributed approximately 18 per cent.
This product mix provides Prasol with exposure to multiple end-use industries. At the same time, the relatively high contribution from acetone-based products creates a degree of concentration risk.
The company’s business could benefit from the China-plus-one strategy, supply-chain diversification and increasing demand for domestic specialty chemical production. However, competition from established Indian and global manufacturers may limit pricing power in some product categories.
Export Presence Creates Opportunities and Risks
Prasol exports to 69 countries, with international markets contributing more than one-fourth of revenue. Its overseas customer base provides geographic diversification and creates opportunities to benefit from global demand for specialty chemicals.
The company’s international operations, however, also expose it to currency fluctuations, overseas economic cycles, regulatory changes and logistics costs. Weak demand in major export markets could affect sales and capacity utilisation.
The specialty chemicals sector is also highly dependent on customer qualification processes. Any delay in product approvals, changes in customer formulations or loss of a major customer could affect revenue growth.
Valuation Is the Main Concern
At the upper price band, Prasol Chemicals is valued at approximately ₹4,000.8 crore. Based on its FY26 earnings, the issue is priced at around 45–47 times earnings, according to the analyst assessment cited in the source article.
Swastika believes the company’s growth and profitability are encouraging, but the valuation leaves limited room for disappointment. The brokerage has suggested that investors may consider the stock after listing, once financial performance stabilises and the valuation becomes more reasonable.
The grey market premium has indicated a possible listing gain, but grey market indications are unofficial, unregulated and subject to rapid changes. They should not be treated as a reliable measure of the company’s intrinsic value or long-term performance.
Large OFS Component Limits Fresh Capital
The IPO includes a fresh issue of only ₹80 crore against an offer for sale of ₹420 crore. This means the majority of the proceeds will go to selling shareholders rather than directly into the company.
Prasol plans to use ₹60 crore from the fresh issue to repay or prepay certain term loans taken from HDFC Bank and Kotak Mahindra Bank. The remaining amount will be used for general corporate purposes.
Debt repayment could reduce finance costs and strengthen the balance sheet. However, the limited fresh capital may restrict the company’s ability to fund large-scale expansion entirely through the IPO proceeds.
Capacity Utilisation and Concentration Risks
Prasol operates manufacturing facilities at Khopoli and Mahad in Maharashtra. Capacity utilisation at the Mahad plant improved from 12.7 per cent in FY24 to 44.1 per cent in FY26, but remains relatively low.
Improving utilisation will be essential for generating operating leverage and improving return ratios. If demand growth is slower than expected, the company may find it difficult to fully utilise its existing capacity.
The company also faces customer and supplier concentration risks. The top 10 customers account for approximately 23.7 per cent of revenue, while the top 10 suppliers contribute nearly 69 per cent of raw-material costs. This creates exposure to customer loss, supplier disruptions and changes in input prices.
Market Outlook
Prasol Chemicals offers exposure to the specialty chemicals industry, import substitution, export growth and complex chemical manufacturing. Its expanding product portfolio, improving profitability, international presence and debt-reduction plan are positive factors.
However, the IPO carries a relatively high valuation, a large offer-for-sale component, low capacity utilisation and dependence on a concentrated supplier base. The company’s earnings are also exposed to raw-material price volatility and fluctuations in global demand.
The issue may appeal to investors with a high risk tolerance and a long-term investment horizon. Conservative investors may prefer to wait for the listing, track quarterly earnings and assess whether capacity utilisation, cash flows and margins improve sufficiently to justify the premium valuation.